ProShares Ultra Nasdaq Biotechnology BIB
Morningstar’s Analysis BIB
There is no Morningstar’s Analysis data available.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 47.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
United States Treasury Bills 0% | 16.40 | 14.8 Mil | Government |
Cte ? Proshares Trust M | 14.01 | 12.6 Mil | — |
Amgen Inc | 6.24 | 5.6 Mil | Healthcare |
Regeneron Pharmaceuticals Inc | 5.66 | 5.1 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 5.46 | 4.9 Mil | Healthcare |
Gilead Sciences Inc | 5.18 | 4.7 Mil | Healthcare |
Moderna Inc | 3.40 | 3.1 Mil | Healthcare |
AstraZeneca PLC ADR | 3.21 | 2.9 Mil | Healthcare |
Biogen Inc | 2.34 | 2.1 Mil | Healthcare |
Alnylam Pharmaceuticals Inc | 1.39 | 1.3 Mil | Healthcare |